Genmab A/S (DE:GE9)
BERLIN:GE9
Holding DE:GE9?
Track your performance easily

Genmab A/S (GE9) Stock News & Sentiment

9 Followers
Genmab A/S’ New Regulation Risk – A Cause for Worry?
Premium
Market News
Genmab A/S’ New Regulation Risk – A Cause for Worry?
9M ago
Genmab A/S (GB:0MGB) has disclosed a new risk, in the Regulation category. Genmab A/S, like many in the biopharmaceutical industry, must navigate a complex web of healthcare laws and regulations, ...Read more
Genmab A/S (0MGB) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Genmab A/S (0MGB) Q4 Earnings Cheat Sheet
9M ago
0MGB Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0MGB Earnings this Week: How Will it Perform?
2y ago

News Score - Last 7 Days

Neutral
DE:GE9
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:GE9’s Media Buzz Sentiment?
1 articles about DE:GE9 were published this week. In an average week, 1 articles are published.
    What is DE:GE9’s weekly average amount of articles?
    In an average week, 1 articles about DE:GE9 are published.
      What is DE:GE9’s News Sentiment?
      50% of articles about DE:GE9 were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        IMCRImmunocore Holdings
        S5YASigma Healthcare Ltd
        KURAKura Oncology
        LIVNLivaNova
        HAEHaemonetics
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis